De novo podocytopathy following moderna COVID-19 vaccine: A case report and racial disproportionality in adverse effect reports
Description
In this study, we report a case of de novo minimal change disease shortly after the second dose of the Moderna COVID-19 vaccine. A previously healthy 51-year-old Asian man presented with lower-limb edema and foamy urine 3 days after receiving the